• No results found

Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab

N/A
N/A
Protected

Academic year: 2020

Share "Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Study schema for phase 2 randomized trial of bevacizumab or placebo in patients with previously treated metastatic renal cell carcinoma.Drawn from data of Yang JC et al.33Abbreviations: ORR, overall response rate;  TTP, time to progression; OS, overall survival.
Figure 3 Study schema for phase 2 randomized trial of bevacizumab plus placebo versus bevacizumab plus erlotinib in patients with treatment-naïve metastatic renal cell carcinoima.Drawn from data of Bukowski et al.41
Figure 4 Treatment schema and results in phase 3 randomized trials utilizing interferon alpha (IFN-α) with/without bevacizumab
Table 1 Risk group survivals in phase 3 bevacizumab trials
+2

References

Related documents

Likewise, the verbal affix has the virtue to value the unvalued accusative case on the animal coding thematic objects in verbal structures, whereas in non-verbal structure, the

Applying the health promotion model, the purpose of this study was to examine direct and/or indirect effects of individual characteristics (gender, school, and other control

This Employer Focus Group felt that the BIT program gave the gradu- ates the skills, experiences and confidence needed to become successful team mem- bers of their

sexual abuse, the report urged the church to consider how the rights of children are affected by its teachings on sexual orientation, given the violence perpetrated against

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF FOSINOPRIL SODIUM, HYDROCHLOROTHIAZIDE IN TABLET DOSAGE FORM BY RP-HPLC.. Uma

Upon analysis, it can easily be generalized that the five characteristics feature (trigger of change, change agent, social mechanism of change, social implication and social

Results: A total of 209 patients met the criteria for entry into the study. Of these, 63.6% had LVH using Cornell criteria and 68.2% using LVH by Sokolow–Lyon criteria. Subsequently,

Ali Babar, Towards Process Support for Migrating Applications to Cloud Computing, International Conference on Cloud and Service Computing (CSC), 2012. Ali Babar, Cloud